cardiac resynchronization therapy
- Access DeniedPrior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, John J.V. McMurray, et al.JACC: Heart Failure
- Access DeniedCardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure PatientsA Systematic Review and Meta-AnalysisGabriel A. Hernandez, Sandra Chaparro, et al.JACC: Heart Failure
- Access DeniedImpact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for TherapyKristin J. Lyons, Gregg C. Fonarow, et al.JACC: Heart Failure
- Access DeniedEconomic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart FailureProjections From the REVERSE Long-Term Follow-UpMichael R. Gold, William T. Abraham, et al.JACC: Heart Failure
- Access DeniedReturn on Investment in Implantable DevicesCardiac Resynchronization Therapy in Mildly Symptomatic Heart FailureBenjamin A. Steinberg, Robert J. Mentz, et al.JACC: Heart Failure
- Access DeniedA Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted DevicesResults From the MultiSENSE StudyJohn P. Boehmer, Jagmeet P. Singh, et al.JACC: Heart Failure
- Access DeniedOutcomes With Left Bundle Branch Block and Mildly to Moderately Reduced Left Ventricular FunctionChance M. Witt, Yong-Mei Cha, et al.JACC: Heart Failure
- Access DeniedLeft Bundle Branch BlockIs it “Unsafe at Any Speed”?Edward Sze, James P. Daubert, et al.JACC: Heart Failure
- Access DeniedLessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION TrialMichael R. Bristow, David L. DeMets, et al.JACC: Heart Failure
- Access DeniedPromoting Transparency in TrialsLessons From the COMPANION InvestigatorsEmily P. Zeitler, Eric D. Peterson, et al.JACC: Heart Failure
Pages
Advertisement